http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1897877-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28e3113097dd6d28720572e47f2f2407
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C30B7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
filingDate 2001-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43b47cd8db691041d3b6278ce8e64cd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9ac002f1f12e79b3ad641dbd13542f0
publicationDate 2008-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1897877-A3
titleOfInvention Process for producing crystal
abstract The present invention relates to a production method of a crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]benzimidazole · n'H 2 O (wherein n' is about 0 to about 0.1) or a salt thereof, which characteristically includes crystallization from an organic solvent solution or suspension in which (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-benzimidazole · nH 2 O (wherein n is about 0.1 to about 1.0) or a salt thereof has been dissolved or suspended, and the like, and provides a convenient method for efficiently producing an optically active sulfoxide derivative having an extremely high enantiomer excess in high yield at an industrial large scale.
priorityDate 2000-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9702261-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0302720-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9821201-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0078745-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0102389-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9828294-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1191025-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9578005
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8442
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426147363
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128604169
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395085
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3883

Total number of triples: 32.